Peculiarities of heart risk in patients with non - alcoholic fatial liver disease


Cite item

Full Text

Abstract

Aim. The purpose of the study is to assess the characteristics of heart risk variability in patients with non - alcoholic fatty liver disease (NAFLD). Materials and methods. The study included 103 patients. All patients were divided into three groups. The first group is 34 healthy patients. The second group - 34 patients with a diagnosis of coronary artery disease; exertional angina II-III FC. The third group - 35 patients diagnosed with NAFLD and type 2 diabetes. An assessment of abdominal circumference, body mass index, ALT, AST, XC, HDL, LDL, TG, glucose and the level of glycated hemoglobin (HbA1c), liver ultrasound and daily ECG monitoring with the determination of HRV were evaluated. Evaluated HRV using statistical analysis: avNN, ms; pNN 50%; SDNNidx, ms; SDNN, ms; SDNNidx, ms; RMSSD, ms. HRV characteristics were evaluated: VLF, LF, HF, LF/HF. Results. Compared with the first group, the increase in cholesterol in patients in the second group was noted by 38.8%, in the third group - by 43.7%, TG - by 34.6 and 41.95%. In patients with NAFLD + DM of the second type, SDNN and SDNNidx decreased in comparison with the healthy patients by 15% (p<0.05) and 14.7% (p<0.05), respectively. A tendency towards sympatovagal displacement of the LF/HF balance in the group NAFLD + type 2 diabetes towards sympathoadrenal effects compared with the group of healthy and IHD patients by 34 and 40% (p<0.1) was revealed. Conclusion. Patients with NAFLD and diabetes of the second type showed a decrease in total HRV, which indicates an increase in their risk of sudden cardiac death. Reduction of HRV in NAFLD and diabetes of the second type can be a predictor of the development and progression of cardiovascular diseases.

About the authors

L M Mosina

National Research Ogarev Mordovia State University

Saransk, Russia

V V Stolyarova

National Research Ogarev Mordovia State University

Saransk, Russia

M V Esina

National Research Ogarev Mordovia State University

Saransk, Russia

Yu V Titojkina

National Research Ogarev Mordovia State University

Saransk, Russia

D M Korobkov

National Research Ogarev Mordovia State University

Saransk, Russia

References

  1. Chalasani N, Younossi Z, Lavine J.E, et al. The diagnosis and management of non - alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005-23. doi: 10.1002/hep.25762
  2. Anstee Q.M, Targher G, Day C.P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10:330-44. doi: 10.1038/nrgastro.2013.41
  3. Ивашкин В.Т., Маевская М.В., Павлов Ч.С. и др. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(2):24-42.
  4. Широкова Е.И. Неалкогольная жировая болезнь печени, гиперлипидемия и сердечно - сосудистые риски. Consilium Medicum. 2017;(8-2):74-6.
  5. Неалкогольная жировая болезнь печени: клиника, диагностика, лечение (рекомендации для терапевтов, 2-я версия). Утверждены XVI Съездом Научного общества гастроэнтерологов России (НОГР) и XI Национальным конгрессом терапевтов 25 ноября 2016 г.
  6. Широкова Е.Н. Неалкогольная жировая болезнь печени и кардиоваскулярный риск. Фарматека. 2017;2(335):24-9.
  7. Targher G, Mantovani A, Pichiri I, Rigolon R, et al. Nonalcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Clin Sci (Lond). 2013;125:301-9. doi: 10.1042/CS20130036
  8. Targher G, Valbusa F, Bonapace S, Bertolini L, et al. Association of non - alcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2014;24:663-9. doi: 10.1016/j.nu-mecd.2014.01.005
  9. Бокерия Л.А., Бокерия О.Л., Базарсадаева Т.С. Новые предикторы внезапной сердечной смерти. Анналы аритмологии. 2009;(4):41-9.
  10. Ардашев А.В., Арутюнов Г.П., Желяков Е.Г., Беленков Ю.Н. Механизмы и причины внезапной сердечной смерти. Факторы и стратификация риска в клинической практике. Основные определения и термины. Клиническая практика. 2014;(4):3-12.
  11. Бокерия Л.А., Бокерия О.Л., Волковская И.В. Вариабельность сердечного ритма: методы измерения, интерпретация, клиническое использование. Анналы аритмологии. 2009;(4):21-32.
  12. Шляхто Е.В., Арутюнов Г.П., Беленков Ю.Н., Ардашев А.В. Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти. Архивъ внутренней медицины. 2013;(4):5-15.
  13. Масюков С.А., Дедов Д.В., Эльгардт И.А. Предикторы кардиоваскулярных осложнений по данным суточной вариабельности сердечного ритма. Современные проблемы науки и образования. 2015;(6). Доступно по ссылке: https://www.science-education.ru/ru/article/view?id=227 (ссылка активна на 05.11.2018.
  14. Xhyheri B, Manfrini O, Mazzolini M, Pizzi C, et al. Heart Rate Variability Today. Progr Cardiovasc Dis. 2012;55(3):321-31. doi: 10.1016/j. pcad.2012.09.001
  15. Kumar M.S, Singh A, Jaryal A.K, et al. Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease. Int J Hepatol ‘Hindawi’. 2016;2016:Article ID5160754. 8 p. doi: 10.1155/ 2016/5160754

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies